Preparation of cycloalkylpyrazole derivatives for use as FXR modulators.

  • Benson G
  • Bleicher K
  • Grether U
  • et al.
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.

Abstract

Title compds. I [A = CH2 or (CH2)3; R1 = (un)substituted Ph, naphthyl or heteroaryl; R2 = H, Me, Et, OH, OMe, F, CH2F, CHF2, or CF3; R3 = heterocyclyl, cycloalkylalkyl, (un)substituted cycloalkyl, or Ph; R4 = C(O)NH(alkyl), CH2O-alkyl, (un)substituted OPh, etc.], and their pharmaceutically acceptable salts, are prepd. and disclosed as FXR modulators. Thus, e.g., II was prepd. by multistep procedure (prepn. given). I were evaluated in FXR radioligand binding assays, e.g., II demonstrated an IC50 value of 28.7 μM. [on SciFinder(R)]

Cite

CITATION STYLE

APA

Benson, G. M., Bleicher, K., Grether, U., Kuhn, B., Richter, H., & Taylor, Sven. (2011, September 29). Preparation of cycloalkylpyrazole derivatives for use as FXR modulators. PCT Int. Appl. F. Hoffmann-La Roche AG, Switz. .

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free